Rench Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Buy
21,919
+5,678
+35% +$454K 0.41% 40
2025
Q4
$1.55M Buy
16,241
+11,381
+234% +$1.12M 0.44% 40
2025
Q3
$474K Buy
+4,860
New +$503K 0.14% 44

Other funds holding BSX

Rench Wealth Management's BSX Position: Q1 2026 in Review

Rench Wealth Management increased its Boston Scientific (BSX) stake by 35% in Q1 2026, buying an estimated $454K and bringing the position to 21,919 shares worth $1.38M. The position accounts for 0.41% of the portfolio, ranked #40.

Rench Wealth Management first reported a position in BSX in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.55M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Rench Wealth Management held 21,919 shares of Boston Scientific worth $1.38M as of Q1 2026.
  • Rench Wealth Management bought 5,678 Boston Scientific shares in Q1 2026, an estimated $454K.
  • Boston Scientific made up 0.41% of Rench Wealth Management's portfolio in Q1 2026, its #40 holding.
  • Rench Wealth Management first reported a position in Boston Scientific in Q3 2025 and has held it in 3 quarters since.
  • Rench Wealth Management's Boston Scientific position peaked at $1.55M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Rench Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.